S. Chea

$VREOF: @Vireo_Growth's Strong Revenue Growth Supports Price Target of $1.50 buff.ly/OKOYv2g

🚨In private meeting, Colorado marijuana regulators acknowledge extent of illegal hemp sales ⚠️“the amount of chemically converted hemp being illegally sold as marijuana is far greater than the agency has publicly disclosed” denvergazette.com/2026/05/15/in-…

Maybe stop forcing legal cannabis businesses to be cash only? Federal cannabis law needs to align with federal policy to stomp out illicit activity. ➡️Safe Banking ➡️STATES 2.0 Act

News Release-->BioHarvest Sciences Reports First Quarter 2026 Financial Results Read Full Release: ir.bioharvest.com/news/default.a…

Q1 Earnings Conference Call to be held May 14, 8am ET. Join Webcast: events.q4inc.com/attendee/38718…

New Research Report: MariMed Inc (MRMD) – Solid First Quarter $MRMD #Investing #EquityResearch #CannabisOperator #Cultivation #Production channelchek.com/news-channel/m…

BREAKING: Pot Inc. may finally be inching closer to the US bank access it craves nypost.com/2026/05/15/bus…

Sen. John Fetterman (D-PA) praised President Donald Trump's moves to reschedule marijuana and accelerate therapeutic access to psychedelics, saying "we could all agree" on the reforms. marijuanamoment.net/fetterman-prai…

Pot Inc. may finally be inching closer to the US bank access it craves trib.al/ps84hng

I interviewed Tim Scott at Milken last week. He chairs the Banking Committee — and based on what he said, Republicans are softening their stance on banking regulation. Cannabis is a $50 billion business that can't open a bank account. If this bill passes, that changes overnight. @BobSloanS3 and I break it down on the new episode of Risk & Return. Full episode ⬇️ youtube.com/watch?v=jWK1AC…

🚨 WOW! DEMOCRAT former Rep. Harold Ford Jr. just confirmed Spencer Pratt is SURGING in the Los Angeles mayoral race — for one very simple reason "He's offering ANSWERS and SOLUTIONS — whether you agree, he's offering answers to real PROBLEMS!" 👏🏻 "Democrats wonder why Spencer Pratt may be finding some traction in Los Angeles...he's actually offering answers to real problems. That's what's missing in politics." "People don't like Democrats working Republicans. Democrats don't like Democrats working with Trump. But we've got to get back to offering answers." @spencerpratt LFG, full steam to defeating Karen Bass!

$MRMD Q1’26 — operational discipline, refined for the post-April 23 rescheduling reality. THE PRINT • Revenue $39.5M (+4.2% YoY) — Wholesale +4.4%, Retail +4.8% • Adj EBITDA $3.6M (+43% YoY), margin 9.1% vs 6.6% • GAAP op income flipped positive: +$125K vs -$910K • Gross margin -110 bps (38.7% vs 39.8%) — best-in-class vs MSO peers running -200 to -400 bps OPERATING LEVERAGE Revenue +4.2% → Adj EBITDA +43%. ~10x incremental margins. • Bad debt: $76K vs $1,388K (cleanup done) • Personnel -1.2%, Marketing -16% YoY • Both channels growing — no channel cannibalization THE 280E REAL OPTION — why April 23 matters The DEA Final Order moved two narrow categories to Schedule III: FDA-approved marijuana products and state-licensed MEDICAL marijuana. Adult-use stays Schedule I until the June 29 expedited hearing produces a broader rule. For MRMD specifically: • Medical revenue gets immediate 280E relief • Adult-use (majority of mix) stays under 280E for now • Tax accounting fragments: medical = deductible, adult-use = not The Q1 numbers through this lens: • $2.65M tax provision on a $1.1M pre-tax LOSS — annualized $10.6M of phantom 280E taxes • $29.6M income taxes payable on the balance sheet, +$2.6M QoQ — accrued but deferred • Acting AG Blanche explicitly “encouraged” Treasury to consider retrospective 280E relief for periods operators held state medical licenses — not granted, but the door is open CATALYST PATH 1.June 29: expedited hearing on broader (adult-use) rescheduling begins 2.Broader final rule: timing uncertain, executive priority 3.IRS guidance on retrospective relief: asymmetric upside, no downside 4.Litigation risk: treaty-authority pathway likely challenged; injunctions possible If the broader rule lands: full revenue base gets 280E relief, normalized tax bill drops near zero on current op loss, the $29.6M accrued liability becomes negotiable, and uplisting optionality (CSE/OTCQB → NYSE/Nasdaq) opens. CAPITAL STACK March 2 Series B restructuring eliminated Feb ’26 mandatory conversion. $14.725M conversion risk → $6.9M new mezz + ~$5.8M long-dated notes. WAM 4.6 yrs. $699K extinguishment gain. Near-term refi risk: gone. WHAT TO WATCH • Cash $7.9M — tight, watch burn (operating CF +$0.9M Q1) • Inventory +$2.7M QoQ — channel build for rescheduling, or stale-product risk? • Long-term notes +$5.8M QoQ — net leverage rising • Accumulated deficit $131.7M — no margin for execution error TAKEAWAY The market is pricing partial rescheduling as the ceiling. The June 29 hearing is the binary catalyst that flips the equation. Operational execution is already best-in-class. The asymmetry is in the optionality nobody wants to underwrite. Not the biggest name in cannabis. Among the cleanest setups. #cannabis #280E

BIG: The House of Representatives passed amendments to allow military veterans to get medical cannabis recommendations from their Department of Veterans Affairs doctors and to raise awareness about the benefits of psychedelic therapies. marijuanamoment.net/house-votes-to…

Solid Q1 from @Vireo_Growth - good growth, margins quite strong, clean balance sheet. The assets they picked up in MO/NV/UT were clearly top-tier. Now the question is how they integrate/right-size the more distressed deals going into Q2 investors.vireogrowth.com/news/news-deta…

“Patel told Collins that the FBI and Department of Homeland Security have created Homeland Security Task Forces in 59 locations across the country, with a specific focus on marijuana grow houses tied to Chinese nationals.” #SmokeShopGate

We released our Q1 2026 earnings results this evening: bit.ly/432RF4y Join our call tomorrow morning at 8a ET to learn more: bit.ly/4nuRqsD $mrmd #cannabis #potstocks #msogang

News Release--> BioHarvest Sciences Signs $1.2M CDMO Stage 2 Contract for the Development of a Rare Fragrance Using its Proprietary Botanical Synthesis Platform. View news release: ir.bioharvest.com/news/default.a… The source plant is widely regarded as one of the most valuable fragrance raw materials in the world.

News Release--> BioHarvest Sciences Announces Successful Completion of Stage 1 Development of Saffron Composition for Nutraceutical and Culinary Applications. CDMO program now advances to Stage 2 of ongoing development agreement. Read Full Release: ir.bioharvest.com/news/default.a…

🚫 The DEA has once again made clear that intoxicating cannabinoids chemically synthesized from hemp are still considered federally illegal Schedule I substances, despite years of industry claims to the contrary. The agency's latest order specifically targets HHC, but it also reinforces the DEA's broader position that the 2018 Farm Bill did not legalize lab-derived intoxicating cannabinoids simply because they originate from hemp. 🔗 Read more: norml.org/news/2026/05/0…

@aaronvalue Got it. Thanks

@SChea316905 No, I'm not, & I don't care about a reverse split. What they are doing is turning debt laden assets & exchanging equity for that debt, relieving the pressure on those assets and then working on improving operations by investing in those operations from a strong balance sheet.

$VREOF has the 2nd best GM% and EBITDA% by any MSO and is now the #4 largest by revenue. Vireo is also the largest cannabis company by revenue in Colorado, Utah and Nevada. Minnesota is likely next to the list. CEO says there are "too many" acquisition opportunities.